A program added to usual kidney care
The trial included people aged at least 45 with stage 4 or 5 chronic kidney disease who were not on dialysis. Participants were randomly assigned to a remotely supported home exercise program added to usual kidney care, or to usual care alone.
The intervention lasted 12 weeks. The primary outcome was the change in distance covered during a six-minute walk test. The researchers also assessed physical performance, sarcopenia risk, fatigue, mood symptoms, sleep and quality of life.
Among participants in the exercise group, 40% used a web platform and 60% received support by video. The abstract does not provide enough detail about the content, intensity or frequency of the exercises to reproduce the program.
Walking improved while the control group declined
The analysis covers the 51 participants who completed the study: 25 in the exercise group and 26 in the control group. Walking distance increased by an average of 29.41 meters in the exercise group, compared with an average decrease of 19.27 meters with usual care alone. The difference remained statistically significant after adjustment for covariates.
This result reflects an improvement in a measured functional capacity, not simply a biological marker. However, the abstract does not establish how many participants experienced a noticeable benefit in daily life.
The authors also report statistically significant improvements in secondary outcomes. Without the magnitudes of these effects in the abstract, their practical importance remains difficult to assess. A reduction in sarcopenia risk does not, on its own, demonstrate a gain in muscle mass.
An encouraging signal, not a ready-made prescription
The trial supports the potential value of supported home exercise for physical capacity in this population. It cannot isolate the contribution of remote support from that of exercise itself, since the control group received only usual care.
The small sample, short duration and analysis restricted to participants who completed the study limit the scope of the finding. Few patients had stage 5 disease, and extrapolation to people on dialysis is not justified.
The abstract does not detail adverse events. It is therefore insufficient to establish the program’s safety or to recommend an unsupervised routine for people with advanced kidney disease.
Limitations to keep in mind
Only the PubMed abstract was consulted, not the full text. The sample is small, and the analysis covers participants who completed the study. The precise exercise arrangements, adverse events, funding and conflicts of interest could not be verified.
What we can take away
In this small trial, 12 weeks of remotely supported home exercise improved walking capacity in patients with advanced kidney disease who were not on dialysis. Whether the benefit persists and whether it affects kidney disease progression remain unknown.
Sources and provenance
- Effects of a telehealth-supported home-based exercise program on functional capacity, sarcopenia risk, and patient-reported outcomes in non-dialysis stage 4-5 chronic kidney disease.
Source date: 2026-10-30.
Journal Article, Randomized Controlled Trial · Résumé PubMed uniquement, texte intégral non consulté